| human | Q5 |
| P166 | award received | Rhodes Scholarship | Q1204346 |
| P69 | educated at | Trinity College, Oxford | Q73079 |
| P106 | occupation | researcher | Q1650915 |
| Q90731240 | A phase II study of reduced intensity double umbilical cord blood transplantation using fludarabine, melphalan, and low dose total body irradiation |
| Q36402045 | A prognostic score for patients with acute leukemia or myelodysplastic syndromes undergoing allogeneic stem cell transplantation. |
| Q43458651 | Absolute lymphocyte count recovery after allogeneic hematopoietic stem cell transplantation predicts clinical outcome |
| Q33815631 | Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantation. |
| Q35533586 | Angiogenic cytokines are antibody targets during graft-versus-leukemia reactions. |
| Q47402442 | Antibodies targeting surface membrane antigens in patients with chronic graft-versus-host disease |
| Q37123927 | Autologous CLL cell vaccination early after transplant induces leukemia-specific T cells |
| Q36212400 | Bortezomib-based graft-versus-host disease prophylaxis in HLA-mismatched unrelated donor transplantation |
| Q36920466 | Circulating T follicular helper cells with increased function during chronic graft-versus-host disease |
| Q34620456 | Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis |
| Q39674948 | Does FLT3 mutation impact survival after hematopoietic stem cell transplantation for acute myeloid leukemia? A Center for International Blood and Marrow Transplant Research (CIBMTR) analysis |
| Q35769347 | Donor chimerism early after reduced-intensity conditioning hematopoietic stem cell transplantation predicts relapse and survival |
| Q37685590 | Donor-specific anti-HLA antibodies predict outcome in double umbilical cord blood transplantation. |
| Q93021290 | Dose-escalated interleukin-2 therapy for refractory chronic graft-versus-host disease in adults and children |
| Q30408294 | Effect of postremission therapy before reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia in first complete remission |
| Q37076418 | Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host disease |
| Q64089252 | Functional analysis of clinical response to low-dose IL-2 in patients with refractory chronic graft-versus-host disease |
| Q36055055 | HLA Mismatch Is Associated with Worse Outcomes after Unrelated Donor Reduced-Intensity Conditioning Hematopoietic Cell Transplantation: An Analysis from the Center for International Blood and Marrow Transplant Research |
| Q35140097 | Ibrutinib treatment ameliorates murine chronic graft-versus-host disease |
| Q58415027 | Impact of Thrombotic Microangiopathy on Renal Outcomes and Survival after Hematopoietic Stem Cell Transplantation |
| Q33781179 | Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliterans |
| Q36036340 | Increased mitochondrial apoptotic priming of human regulatory T cells after allogeneic hematopoietic stem cell transplantation. |
| Q35078368 | Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research |
| Q35525729 | Low telomerase activity in CD4+ regulatory T cells in patients with severe chronic GVHD after hematopoietic stem cell transplantation. |
| Q42737854 | Prediction of veno-occlusive disease using biomarkers of endothelial injury |
| Q38922717 | Rb and FZR1/Cdh1 determine CDK4/6-cyclin D requirement in C. elegans and human cancer cells |
| Q46816156 | Reduced-intensity conditioning stem cell transplantation: comparison of double umbilical cord blood and unrelated donor grafts |
| Q57044016 | Small-molecule BCL6 inhibitor effectively treats mice with non-sclerodermatous chronic graft-versus-host disease |
| Q34396189 | Somatic mutations predict poor outcome in patients with myelodysplastic syndrome after hematopoietic stem-cell transplantation |
| Q35784522 | Targeting Syk-activated B cells in murine and human chronic graft-versus-host disease |
| Q28770084 | Toward improving Caenorhabditis elegans phenome mapping with an ORFeome-based RNAi library |
| Q34827332 | Use of matched unrelated donors compared with matched related donors is associated with lower relapse and superior progression-free survival after reduced-intensity conditioning hematopoietic stem cell transplantation |
| Q33650918 | White blood cell recovery after allogeneic hematopoietic cell transplantation predicts clinical outcome |
Search more.